Welcome to our dedicated page for Varex Imaging Corporation news (Ticker: VREX), a resource for investors and traders seeking the latest updates and insights on Varex Imaging Corporation stock.
Varex Imaging Corporation (Nasdaq: VREX) is the world’s largest independent supplier of medical X-ray tubes and image processing solutions. With a mission to be the leader in imaging components by delivering high-quality products that enable customer success, Varex Imaging serves a variety of industries, from medical imaging to cargo screening and border security.
Core Business: Varex Imaging operates in two main segments: Medical and Industrial. The Medical segment, the key revenue driver, designs, manufactures, sells, and services a range of X-ray imaging components such as X-ray tubes, digital flat panel image detectors, high voltage connectors, ionization chambers, and buckys. The Industrial segment focuses on components like Linatron X-ray accelerators, digital flat panel detectors, and high voltage connectors. These components are integral to X-ray imaging systems used worldwide for diagnosis, detection, and protection.
Recent Achievements and Projects: Varex Imaging has an extensive catalog of innovative and cost-effective X-ray imaging solutions. The company conducts manufacturing, research, and development operations in the United States, Europe, the Philippines, and China, with sales and service operations globally. Varex's commitment to innovation is evident through its continual development of high-voltage connectors, X-ray collimators, ionization chambers, and mammography paddles, among others.
Financial and Partnerships: Varex Imaging has solidified its position in the market through strategic partnerships and a robust financial outlook. The company's products help their customers become world-class system suppliers by harnessing the power of X-ray energy to pioneer advances in various applications.
Overall, Varex Imaging Corporation stands out as a key player in the imaging components industry, driving advancements that benefit both medical and industrial applications.
Varex Imaging (Nasdaq: VREX) announced its unaudited financial results for the second quarter of fiscal year 2024, with revenues of $206 million. The GAAP gross margin was 32%, while the Non-GAAP gross margin stood at 33%. GAAP net earnings were $0.03 per diluted share, and Non-GAAP net earnings were $0.16 per diluted share. Cash flow from operations was $3 million. The company reported a 10% year-over-year decrease in revenue, primarily due to lower sales in China. The medical segment revenue was down 15%, while the industrial segment revenue was up 6%. Non-GAAP gross margin was 33%, with Non-GAAP EPS decreasing to $0.16 from $0.26 in the previous year. Cash, cash equivalents, marketable securities, and CDs totaled $190 million at the end of the quarter. The company provided guidance for the third quarter, expecting revenues between $200 million and $220 million and Non-GAAP net earnings per diluted share between $0.05 and $0.25.
FAQ
What is the current stock price of Varex Imaging Corporation (VREX)?
What is the market cap of Varex Imaging Corporation (VREX)?
What does Varex Imaging Corporation do?
What are the main segments of Varex Imaging’s business?
Where are Varex Imaging’s operations located?
What products does Varex Imaging manufacture?
What industries use Varex Imaging’s products?
How does Varex Imaging contribute to innovation?
What is the mission of Varex Imaging Corporation?
Which segment is the key revenue driver for Varex Imaging?
Who are the customers of Varex Imaging?
What are some recent achievements of Varex Imaging?
